Business Description
Pharmala Biotech Holdings Inc
NAICS : 541714
SIC : 3741
ISIN : CA71719L1067
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.16 | |||||
Equity-to-Asset | 0.54 | |||||
Debt-to-Equity | 0.19 | |||||
Debt-to-EBITDA | -1.22 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 0.85 | |||||
Beneish M-Score | 3.53 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 73.74 | |||||
9-Day RSI | 63.36 | |||||
14-Day RSI | 57.19 | |||||
6-1 Month Momentum % | -49.74 | |||||
12-1 Month Momentum % | -60.14 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.6 | |||||
Quick Ratio | 0.59 | |||||
Cash Ratio | 0.04 | |||||
Days Inventory | 93.91 | |||||
Days Sales Outstanding | 35.12 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 71.12 | |||||
Operating Margin % | -20.84 | |||||
Net Margin % | -47.31 | |||||
FCF Margin % | -71.76 | |||||
ROE % | -41.29 | |||||
ROA % | -25.36 | |||||
ROIC % | -13.47 | |||||
ROC (Joel Greenblatt) % | -12136.36 | |||||
ROCE % | -18.19 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 5.32 | |||||
PB Ratio | 5.84 | |||||
EV-to-EBIT | -33.34 | |||||
EV-to-EBITDA | -42.74 | |||||
EV-to-Revenue | 7.08 | |||||
EV-to-FCF | -7.84 | |||||
Earnings Yield (Greenblatt) % | -3 | |||||
FCF Yield % | -12.91 |